Atomoxetine potentiated the increase in heart rate and blood pressure caused by
salbutamol infusions in one study, but another study found no adverse interaction.
The manufacturers recommend caution when
atomoxetine is given to patients receiving
intravenous, oral, or high-dose nebulised
salbutamol or other beta2 agonists. Monitor heart rate and blood pressure carefully in the initial stages of combined use.